Skip to main content
. Author manuscript; available in PMC: 2021 Jul 29.
Published in final edited form as: Med Drug Discov. 2020 Mar 24;6:100023. doi: 10.1016/j.medidd.2020.100023

Fig. 7.

Fig. 7.

PEGylated-PLGA nanoparticles co-encapsulated with anti-miRNA-21 and GEM for HCC therapy. Anti-miRNA-21 and GEM co-encapsulated nanoparticles can improve treatment efficiency in HCC cells in comparison to nanoparticles treated with nanoparticles with equal concentrations of individually loaded anti-miRNA-21 and GEM. Adapted by permission from reference [109]. Copyright 2016, American Chemical Society.